Data on rebound trend in individuals with any disease level of SLE who also had permanently withdrawn from further belimumab treatment (long-term discontinuation group [LTD]) were also assessed
Data on rebound trend in individuals with any disease level of SLE who also had permanently withdrawn from further belimumab treatment (long-term discontinuation group [LTD])… Read More »Data on rebound trend in individuals with any disease level of SLE who also had permanently withdrawn from further belimumab treatment (long-term discontinuation group [LTD]) were also assessed